Myelodysplastic Syndrome (MDS) MRD Panel By Flowcytometry in Mumbai

The Myelodysplastic Syndrome (MDS) MRD Panel by Flow Cytometry is a test used to detect and monitor minimal residual disease (MRD) in patients with MDS. MRD refers to the persistence of a small number of cancerous cells after treatment, even when the patient appears to be in remission.